News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement

BioPharm International

Advertisement

Articles by BioPharm International

FDA Approves Keytruda for Cancers with Specific Biomarker

ByBioPharm International
May 26th 2017

EMA Launches Biosimilars Project

ByBioPharm International
December 20th 2016

December 20, 2016

HHS Awards $8.2 Million to Moderna for Zika Vaccine Development

ByBioPharm International
September 9th 2016

September 9, 2016

Pfizer to Acquire Medivation

ByBioPharm International
August 22nd 2016

August 23, 2016

NIH Launches Zika Vaccine Clinical Trial

ByBioPharm International
August 5th 2016

August 05, 2016

Shire Announces $400 Million Ireland Investment

ByBioPharm International
April 18th 2016

April 18, 2016.

FDA's New Quality Metrics Address Industry Concerns

ByBioPharm International
November 24th 2015

November 24, 2015.

Advertisement

Latest Updated Articles

  • FDA's New Quality Metrics Address Industry Concerns
    FDA's New Quality Metrics Address Industry Concerns

    November 24th 2015

  • Shire Announces $400 Million Ireland Investment
    Shire Announces $400 Million Ireland Investment

    April 18th 2016

  • NIH Launches Zika Vaccine Clinical Trial
    NIH Launches Zika Vaccine Clinical Trial

    August 5th 2016

  • Pfizer to Acquire Medivation
    Pfizer to Acquire Medivation

    August 22nd 2016

  • HHS Awards $8.2 Million to Moderna for Zika Vaccine Development
    HHS Awards $8.2 Million to Moderna for Zika Vaccine Development

    September 9th 2016

  • EMA Launches Biosimilars Project
    EMA Launches Biosimilars Project

    December 20th 2016



Advertisement
Advertisement

Trending on PharmExec

1

Novo Nordisk Responds to FDA’s Warning Letter Regarding 2025 PADE Inspection

2

Senate Democrats Expand Efforts to Expose Details of MFN Pharma Deals

3

When Ambition Meets Ambiguity: The Trends and Sentiments Shaping Biotech in 2026

4

FDA Reveals New Guidance for Streamlining Biosimilar Development

5

What Risks and Opportunities Does FDA's Single-Trial Approval Pathway Create?

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us